78N-23854-22904
2 vaccinations
14 coded responses
15 check-ins
14 free-text entries
7 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 447 / OH
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-09
Registered in v-safe
-
2021-04-09
Survey response — day 7, dose 1MedDRA: Hypoaesthesia — Feeling: Fair · Chills, Muscle or body achesFree text: Numb right footMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
-
2021-04-22
Survey response — day 0, dose 2MedDRA: Unevaluable event — Feeling: Fair · ChillsFree text: Foot drop, right footMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia, Peroneal nerve palsy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Foot drop, right foot still numbMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Numb right footMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Numb right footMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Numb right footMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Survey response — day 14, dose 2MedDRA: Gait inability, Peroneal nerve palsy — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Dual foot drop. Cannot walk. MRI scheduled.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — day 21, dose 2MedDRA: Guillain-Barre syndrome, Hospitalisation, Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: I was hospitalized with acute inflammatory demyelinating polyneuropathy · Healthcare visit (other): Your vaccine almost killed meMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-20
Survey response — day 28, dose 2MedDRA: Guillain-Barre syndrome — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Diagnosed with Guillain-Barré syndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-20
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-27
Survey response — day 35, dose 2MedDRA: Guillain-Barre syndrome, Polyneuropathy — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Polyneuropathy, Guillain-Barre SyndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-27
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-05
Survey response — day 42, dose 2MedDRA: Guillain-Barre syndrome — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Guillain-Barre SyndromeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-05
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-22
Survey response — 3 months, dose 2MedDRA: Electromyogram abnormal, Guillain-Barre syndrome, Hospitalisation, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging abnormal, Physiotherapy — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Diagnosed with Guillain-Barre Syndrome confirmed via EMG, MRI, LP. Hospitalized and given IV immunoglobulin. Still in physical therapy.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-22
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-24
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: Guillain-Barre syndrome, Hospitalisation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Hospitalized with Guillain-Barre SyndromeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-10-22
-
2022-04-24
Survey response — 12 months, dose 2MedDRA: Guillain-Barre syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Guillain-Barre SyndromeMedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech |
Call center
7 call center cases
7 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): Numb right foot
Release 7 — day 0, dose 2
Systemic reaction (other): Foot drop, right foot
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Foot drop, right foot still numb
Systemic reaction (other): Numb right foot
Systemic reaction (other): Numb right foot
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Numb right foot
Release 8 — day 14, dose 2
Symptoms: Dual foot drop. Cannot walk. MRI scheduled.
Release 8 — day 21, dose 2
Symptoms: I was hospitalized with acute inflammatory demyelinating polyneuropathy
Healthcare visit (other): Your vaccine almost killed me
Release 8 — day 28, dose 2
Symptoms: Diagnosed with Guillain-Barré syndrome
Release 8 — day 35, dose 2
Symptoms: Polyneuropathy, Guillain-Barre Syndrome
Release 8 — day 42, dose 2
Symptoms: Guillain-Barre Syndrome
Release 9 — 3 months, dose 2
Symptoms: Diagnosed with Guillain-Barre Syndrome confirmed via EMG, MRI, LP. Hospitalized and given IV immunoglobulin. Still in physical therapy.
Release 10 — 6 months, dose 2
Symptoms: Hospitalized with Guillain-Barre Syndrome
Release 11 — 12 months, dose 2
Symptoms: Guillain-Barre Syndrome
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Electromyogram abnormal | · | · | ✓ |
| SD | Gait inability | ✓ | ✓ | ✓ |
| SD | Guillain-Barre syndrome | ✓ | ✓ | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Immunoglobulin therapy | · | · | ✓ |
| SD | Lumbar puncture abnormal | · | · | ✓ |
| SD | Magnetic resonance imaging abnormal | · | · | ✓ |
| SD | Peroneal nerve palsy | ✓ | ✓ | ✓ |
| SD | Physiotherapy | · | · | ✓ |
| SD | Polyneuropathy | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Peroneal nerve palsy | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release